The biotechnology sector’s alluring all-or-nothing approach has pulses racing and valuations soaring. Far from a geeky enterprise, this fascinating industry is on a mission to save lives and improve global health through clinical research and novel drug development. And it’s owning the financial markets along the way. While other industry sectors may have one or two speculative darlings that may skyrocket, this theme is loaded with stocks that have the potential to double in value if R&D goals are accomplished. Big pharma, and public and private investors, are holding their breath waiting for the next big breakthrough. Relax – we’ve done the thinking for you. Our Biotech Revolution theme hedges against the inevitable risk of investing in biotechs by filtering firms with a market capitalisation of over $1 billion and positive sales growth over the past two years, ensuring they are in good stead to fund the next blockbuster.